News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) To Present New Data On Brexpiprazole In Major Depression (MDD) At European Congress Of Psychiatry (EPA)



1/24/2014 9:26:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valby, Denmark and Tokyo, Japan, 24 January 2014 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the first top-line phase III trial data on the investigational compound brexpiprazole will be presented at the 22nd European Psychiatry Association Congress (EPA) in Munich, Germany on 2 March, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES